[1]
2018. Risk of anaphylaxis and conjunctivitis with tralokinumab in atopic dermatitis. SKIN The Journal of Cutaneous Medicine. 2, (Dec. 2018), S63. DOI:https://doi.org/10.25251/skin.2.supp.63.